How to check the XIRR of quant Healthcare Fund - Growth Option - Regular Plan?

You can track the exact XIRR and portfolio overlapping of quant Healthcare Fund - Growth Option - Regular Plan alongside your PMS and AIF investments using the MutualSaathi Portfolio Analyzer.

How to check portfolio overlap for quant Healthcare Fund - Growth Option - Regular Plan?

Use the MutualSaathi Portfolio Analyzer to compare quant Healthcare Fund - Growth Option - Regular Plan with other funds, PMS, and AIFs to detect hidden stock overlaps.

quant Healthcare Fund - Growth Option - Regular Plan

quant Mutual Fund

Expense Ratio: 2.4

Risk: Very High

Equity Scheme - Sectoral/ Thematic

Plan: Regular

Benchmark: NIFTY Healthcare TRI

Inception: 27-06-2023

Exit Load: Nil

Fund Size:₹368.30 Cr

Performance

Fund10.23%

Cat. Avg.N/A

Fund-0.35%

Cat. Avg.N/A

Fund16.96%

Cat. Avg.N/A

FundN/A

Cat. Avg.N/A

10Y

FundN/A

Cat. Avg.N/A

Fund18.18%

Cat. Avg.N/A

Fund Facts

No available Data

Taxation

Within 1 Year (STCG (Short Term)):20%

After 1 Year (LTCG (Long Term)):12.5%

*Tax rates as per Finance Act 2024. Surcharge & cess may apply.

Allocation

Visualizing Fund's Exposure

Asset Class

Tap to expand

Market Cap

Tap to expand

Top Sectors

Tap to expand

Asset Class

Market Cap

Top Sectors

Portfolio Holdings

Detailed breakdown of instruments.

	Instrument	Type	Sub-Cat	Cap	Sector	YTM	Val (Cr)	% Assets
1	TREPS 01-Jul-2026 DEPO 10	CASH	TREPS / Reverse Repo		TREPS / Reverse Repo	5.78%	84.98	21.73%
2	HFCL Limited	Equity	Listed	Small Cap	Telecom - Services		42.09	10.76%
3	Zydus Wellness Ltd	Equity	Listed	Small Cap	Food Products		36.93	9.44%
4	Aurobindo Pharma Limited	Equity	Listed	Mid Cap	Pharmaceuticals & Biotechnology		35.81	9.16%
5	Aster DM Healthcare Limited	Equity	Listed	Mid Cap	Healthcare Services		35.04	8.96%
6	Concord Biotech Limited	Equity	Listed	Small Cap	Pharmaceuticals & Biotechnology		34.56	8.84%
7	Glenmark Pharmaceuticals Ltd	Derivative	Future/Option		Pharmaceuticals & Biotechnology		34.04	8.70%
8	SMS Pharmaceuticals Limited	Equity	Listed	Small Cap	Pharmaceuticals & Biotechnology		31.88	8.15%
9	Max Healthcare Institute Limited	Equity	Listed	Mid Cap	Healthcare Services		30.59	7.82%
10	Alivus Life Sciences	Equity	Listed	Small Cap	Pharmaceuticals & Biotechnology		28.48	7.28%

Similar Funds

Bandhan Liquid Fund - Unclaimed Redemption Less Than 3 Years

Bandhan Mutual Fund

Expense Ratio: 0.23

NAV / Fund Size

₹1.79₹17,474.79 Cr

Incep: 01-01-1900

Liquid FundLow to Moderate RiskDebt

6.21%

6.76%

6.96%

6.13%

6.08%

Fund Details

Bandhan Liquid Fund - Unclaimed Redemption Less Than 3 Years

NAV / Fund Size₹1.79₹17,474.79 Cr

Liquid FundLow to Moderate RiskDebt

6.21%

6.76%

6.96%

6.13%

6.08%

Kotak-Small Cap Fund - Growth

Kotak Mahindra Mutual Fund

Expense Ratio: 1.66

NAV / Fund Size

₹253.83₹17,349.01 Cr

Incep: 30-12-2004

Small Cap FundVery High RiskEquity

-1.47%

2.52%

13.85%

13.72%

13.40%

Fund Details

Kotak-Small Cap Fund - Growth

NAV / Fund Size₹253.83₹17,349.01 Cr

Small Cap FundVery High RiskEquity

-1.47%

2.52%

13.85%

13.72%

13.40%

quant Aggressive Hybrid Fund - Growth Option - Regular Plan

quant Mutual Fund

Expense Ratio: 2.04

NAV / Fund Size

₹463.26₹2,091.79 Cr

Incep: 19-02-2001

Aggressive Hybrid FundVery High RiskHybrid

11.10%

5.74%

15.36%

14.21%

12.47%

Fund Details

quant Aggressive Hybrid Fund - Growth Option - Regular Plan

NAV / Fund Size₹463.26₹2,091.79 Cr

Aggressive Hybrid FundVery High RiskHybrid

11.10%

5.74%

15.36%

14.21%

12.47%

SIP Returns

Amount (₹)

Date

7th

Period	SIP Date	Inv(₹)	Val(₹)	Abs(%)	XIRR
1Y	07 Nov, 25	60000	64883	+8.1%	+17.4%
2Y	07 Nov, 24	1.20 L.	1.33 L.	+10.9%	+10.9%
3Y	07 Nov, 23	1.80 L.	2.08 L.	+15.3%	+9.9%
SI	07 Aug, 23	1.95 L.	2.32 L.	+19.0%	+11.1%

Lumpsum Returns

Amount (₹)

Period	Inv Date	Inv(₹)	Val(₹)	Abs(%)	CAGR
1Y	16 Oct, 25	1 L.	1.10 L.	+10.2%	+10.2%
2Y	16 Oct, 24	1 L.	99307	-0.7%	-0.3%
3Y	16 Oct, 23	1 L.	1.60 L.	+60.0%	+17.0%
SI	18 Jul, 23	1 L.	1.72 L.	+72.1%	+18.2%

SIP Calculator

Visualize how small monthly investments grow over time.

Monthly SIP Amount

Max: ₹10 Cr

₹

Investment Tenure

Max: 40 Years

Years

Expected Annual Return (SIP)

Max: 30%

Expected Inflation

Max: 20%

Annual Step-up

Beat inflation and compound wealth faster with an annual step-up.

Max: 500%

Initial Lumpsum

Max: ₹1000 Cr

₹

Expected Return on Lumpsum

Max: 30%

Future Value

₹23.80L

With SIP Amount ₹5,000

Total Invested

₹9.00L

Total Profit

₹14.80L

SIP Invested₹9.00L

SIP Gain₹14.80L

Lumpsum Inv.₹0

Lumpsum Gain₹0

Reality Check: Your future value will be today's ₹8.62L at inflation rate 7%

Tip: You can set a Goal first in the Goal Planner to calculate SIP targets adjusted for inflation.